{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T17:52:31Z","timestamp":1783792351807,"version":"3.55.0"},"reference-count":74,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3748\/wjg.v22.i4.1405","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T03:31:43Z","timestamp":1453692703000},"page":"1405","source":"Crossref","is-referenced-by-count":20,"title":["Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis"],"prefix":"10.3748","volume":"22","author":[{"given":"Carlo","family":"Palazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i3.616"},{"key":"ref2","unstructured":"Antonelli A, Ferri C, Galeazzi M, Giannitti C, Manno D, Mieli-Vergani G, Menegatti E, Olivieri I, Puoti M, Palazzi C. HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol 2008;26:S39-S47."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i3.327"},{"key":"ref4","unstructured":"Palazzi C, Olivieri I, Cacciatore P, Pennese E, D&rsquo;Amico E. Difficulties in the differential diagnosis between primitive rheumatic diseases and hepatitis C virus-related disorders. Clin Exp Rheumatol 2005;23:2-6."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.11.011"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-25"},{"key":"ref7","unstructured":"Lamprecht P. Cryoglobulinaemic vasculitis: new aspects. Clin Exp Rheumatol 2012;30:S3-S5."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Sansonno D, Lauletta G, Nisi L, Gatti P, Pesola F, Pansini N, Dammacco F. Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. Clin Exp Immunol 2003;133:275-282.","DOI":"10.1046\/j.1365-2249.2003.02204.x"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, Puccini R, Michelassi C, Zignego AL. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004;33:355-374.","DOI":"10.1016\/j.semarthrit.2003.10.001"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Jackson JM. Hepatitis C and the skin. Dermatol Clin 2002;20:449-458.","DOI":"10.1016\/S0733-8635(02)00013-X"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Crowson AN, Nuovo G, Ferri C, Magro CM. The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases. Hum Pathol 2003;34:573-579.","DOI":"10.1016\/S0046-8177(03)00193-X"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Cacoub P, Gragnani L, Comarmond C, Zignego AL. Extrahepatic manifestations of chronic hepatitis C virus infection. Dig Liver Dis 2014;46 Suppl 5:S165-S173.","DOI":"10.1016\/j.dld.2014.10.005"},{"key":"ref13","unstructured":"Sene D, Ghillani-Dalbin P, Thibault V, Guis L, Musset L, Duhaut P, Poynard T, Piette JC, Cacoub P. Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus. J Rheumatol 2004;31:2199-2206."},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"De Rosa FG, Agnello V. Observations on cryoglobulin testing: I. The association of cryoglobulins containing rheumatoid factors with manifestation of cryoglobulinemic vasculitis. J Rheumatol 2009;36:1953-1955.","DOI":"10.3899\/jrheum.081035"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Beddhu S, Bastacky S, Johnson JP. The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore) 2002;81:398-409.","DOI":"10.1097\/00005792-200209000-00005"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i35.12372"},{"key":"ref17","unstructured":"Latt N, Alachkar N, Gurakar A. Hepatitis C virus and its renal manifestations: a review and update. Gastroenterol Hepatol (N Y) 2012;8:434-445."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i24.7544"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-013-0810-z"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Uchiyama-Tanaka Y, Mori Y, Kishimoto N, Nose A, Kijima Y, Nagata T, Umeda Y, Masaki H, Matsubara H, Iwasaka T. Membranous glomerulonephritis associated with hepatitis C virus infection: case report and literature review. Clin Nephrol 2004;61:144-150.","DOI":"10.5414\/CNP61144"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000335375"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Ammendola A, Sampaolo S, Ambrosone L, Ammendola E, Ciccone G, Migliaresi S, Di Iorio G. Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study. Muscle Nerve 2005;31:382-385.","DOI":"10.1002\/mus.20184"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Gemignani F, Brindani F, Alfieri S, Giuberti T, Allegri I, Ferrari C, Marbini A. Clinical spectrum of cryoglobulinaemic neuropathy. J Neurol Neurosurg Psychiatry 2005;76:1410-1414.","DOI":"10.1136\/jnnp.2004.057620"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i8.2269"},{"key":"ref25","unstructured":"Casato M, Saadoun D, Marchetti A, Limal N, Picq C, Pantano P, Galanaud D, Cianci R, Duhaut P, Piette JC. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests. J Rheumatol 2005;32:484-488."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Ramos-Casals M, Robles A, Brito-Zer&oacute;n P, Nardi N, Nicol&aacute;s JM, Forns X, Plaza J, Yag&uuml;e J, S&aacute;nchez-Tapias JM, Font J. Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases. Semin Arthritis Rheum 2006;36:189-196.","DOI":"10.1016\/j.semarthrit.2006.08.005"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Terrier B, Karras A, Cluzel P, Collet JP, S&egrave;ne D, Saadoun D, Cacoub P. Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis. Am J Cardiol 2013;111:265-272.","DOI":"10.1016\/j.amjcard.2012.09.028"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Retamozo S, D&iacute;az-Lagares C, Bosch X, Bov&eacute; A, Brito-Zer&oacute;n P, G&oacute;mez ME, Yag&uuml;e J, Forns X, Cid MC, Ramos-Casals M. Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients. Medicine (Baltimore) 2013;Epub ahead of print.","DOI":"10.1097\/MD.0b013e3182a5cf71"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20381"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Opolon P. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999;42:2204-2212.","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/ar3361"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Katsifis GE, Moutsopoulos NM, Wahl SM. T lymphocytes in Sj&ouml;gren&rsquo;s syndrome: contributors to and regulators of pathophysiology. Clin Rev Allergy Immunol 2007;32:252-264.","DOI":"10.1007\/s12016-007-8011-8"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.10.004"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Freni MA, Artuso D, Gerken G, Spanti C, Marafioti T, Alessi N, Spadaro A, Ajello A, Ferra&ugrave; O. Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity. Hepatology 1995;22:389-394.","DOI":"10.1002\/hep.1840220203"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2007.01436.x"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i24.7534"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Smyth CM, McKiernan SM, Hagan R, Pilkington R, O&rsquo;Regan M, Lawlor E, Kelleher D. Chronic hepatitis C infection and sicca syndrome: a clear association with HLA DQB1*02. Eur J Gastroenterol Hepatol 2007;19:493-498.","DOI":"10.1097\/MEG.0b013e328010687d"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Scott CA, Avellini C, Desinan L, Pirisi M, Ferraccioli GF, Bardus P, Fabris C, Casatta L, Bartoli E, Beltrami CA. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sj&ouml;gren&rsquo;s syndrome. Histopathology 1997;30:41-48.","DOI":"10.1046\/j.1365-2559.1997.d01-561.x"},{"key":"ref39","unstructured":"Toussirot E, Le Hu&eacute;d&eacute; G, Mougin C, Balblanc JC, Bettinger D, Wendling D. Presence of hepatitis C virus RNA in the salivary glands of patients with Sj&ouml;gren&rsquo;s syndrome and hepatitis C virus infection. J Rheumatol 2002;29:2382-2385."},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Arrieta JJ, Rodr&iacute;guez-I\u00f1igo E, Ortiz-Movilla N, Bartolom&eacute; J, Pardo M, Manzarbeitia F, Oliva H, Mac&iacute;as DM, Carre\u00f1o V. In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol 2001;158:259-264.","DOI":"10.1016\/S0002-9440(10)63964-8"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Ramos-Casals M, Garc&iacute;a-Carrasco M, Cervera R, Rosas J, Trejo O, de la Red G, S&aacute;nchez-Tapias JM, Font J, Ingelmo M. Hepatitis C virus infection mimicking primary Sj&ouml;gren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) 2001;80:1-8.","DOI":"10.1097\/00005792-200101000-00001"},{"key":"ref42","unstructured":"De Vita S, Damato R, De Marchi G, Sacco S, Ferraccioli G. True primary Sj&ouml;gren&rsquo;s syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis. Isr Med Assoc J 2002;4:1101-1105."},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"D&rsquo;Amico E, Palazzi C, Cacciatore P, Canelli A, Ursitti G, Cosentino L, Dogali V, Riario-Sforza G, Capani F. Anti-ENA antibodies in patients with chronic hepatitis C virus infection. Dig Dis Sci 2002;47:755-759.","DOI":"10.1023\/A:1014731731363"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS. Classification criteria for Sj&ouml;gren&rsquo;s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558.","DOI":"10.1136\/ard.61.6.554"},{"key":"ref45","unstructured":"Iagnocco A, Coari G, Mammarella A, Basili S, Donnarumma L, Valesini G, Paoletti V. Joint sonography in asymptomatic patients with HCV correlated hepatitis. Clin Exp Rheumatol 2004;22:43-48."},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Buskila D, Shnaider A, Neumann L, Lorber M, Zilberman D, Hilzenrat N, Kuperman OJ, Sikuler E. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 1998;28:107-113.","DOI":"10.1016\/S0049-0172(98)80043-7"},{"key":"ref47","unstructured":"Rivera J, Garc&iacute;a-Monforte A, Pineda A, Mill&aacute;n N&uacute;\u00f1ez-Cort&eacute;s J. Arthritis in patients with chronic hepatitis C virus infection. J Rheumatol 1999;26:420-424."},{"key":"ref48","unstructured":"Lovy MR, Starkebaum G, Uberoi S. Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 1996;23:979-983."},{"key":"ref49","unstructured":"Zuckerman E, Keren D, Rozenbaum M, Toubi E, Slobodin G, Tamir A, Naschitz JE, Yeshurun D, Rosner I. Hepatitis C virus-related arthritis: characteristics and response to therapy with interferon alpha. Clin Exp Rheumatol 2000;18:579-584."},{"key":"ref50","unstructured":"Fadda P, La Civita L, Zignego AL, Ferri C. [Hepatitis C virus infection and arthritis. A clinico-serological investigation of arthritis in patients with or without cryoglobulinemic syndrome]. Reumatismo 2002;54:316-323."},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Olivieri I, Palazzi C, Padula A. Hepatitis C virus and arthritis. Rheum Dis Clin North Am 2003;29:111-122.","DOI":"10.1016\/S0889-857X(02)00097-2"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Rosner I, Rozenbaum M, Toubi E, Kessel A, Naschitz JE, Zuckerman E. The case for hepatitis C arthritis. Semin Arthritis Rheum 2004;33:375-387.","DOI":"10.1016\/j.semarthrit.2003.12.006"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Palazzi C, D&rsquo;Angelo S, Olivieri I. Hepatitis C virus-related arthritis. Autoimmun Rev 2008;8:48-51.","DOI":"10.1016\/j.autrev.2008.07.025"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"S&egrave;ne D, Ghillani-Dalbin P, Limal N, Thibault V, van Boekel T, Piette JC, Cacoub P. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren&rsquo;s syndrome. Ann Rheum Dis 2006;65:394-397.","DOI":"10.1136\/ard.2005.038042"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Bombardieri M, Alessandri C, Labbadia G, Iannuccelli C, Carlucci F, Riccieri V, Paoletti V, Valesini G. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther 2004;6:R137-R141.","DOI":"10.1186\/ar1041"},{"key":"ref56","unstructured":"Riccio A, Postiglione L, La Dogana P, Span&ograve; A, Marzocchella C, Tarantino G. Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis. J Biol Regul Homeost Agents 2008;22:57-61."},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Bassyouni IH, Ezzat Y, Hamdy S, Talaat RM. Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection. Clin Chem Lab Med 2009;47:842-847.","DOI":"10.1515\/CCLM.2009.189"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Buskila D, Shnaider A, Neumann L, Zilberman D, Hilzenrat N, Sikuler E. Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Arch Intern Med 1997;157:2497-2500.","DOI":"10.1001\/archinte.1997.00440420129014"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Goulding C, O&rsquo;Connell P, Murray FE. Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition. Eur J Gastroenterol Hepatol 2001;13:507-511.","DOI":"10.1097\/00042737-200105000-00008"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Kozanoglu E, Canataroglu A, Abayli B, Colakoglu S, Goncu K. Fibromyalgia syndrome in patients with hepatitis C infection. Rheumatol Int 2003;23:248-251.","DOI":"10.1007\/s00296-003-0290-7"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1463-x"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3182485528"},{"key":"ref63","unstructured":"Narv&aacute;ez J, Nolla JM, Valverde-Garc&iacute;a J. Lack of association of fibromyalgia with hepatitis C virus infection. J Rheumatol 2005;32:1118-1121."},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Palazzi C, D&rsquo;Amico E, D&rsquo;Angelo S, Nucera A, Petricca A, Olivieri I. Hepatitis C virus infection in Italian patients with fibromyalgia. Clin Rheumatol 2008;27:101-103.","DOI":"10.1007\/s10067-007-0737-4"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/871401]."},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Prieto J, Yuste JR, Beloqui O, Civeira MP, Riezu JI, Aguirre B, Sangro B. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996;23:199-204.","DOI":"10.1002\/hep.510230201"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Rajan SK, Espina BM, Liebman HA. Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura. Br J Haematol 2005;129:818-824.","DOI":"10.1111\/j.1365-2141.2005.05542.x"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Wu YY, Hsu TC, Chen TY, Liu TC, Liu GY, Lee YJ, Tsay GJ. Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection. Clin Exp Immunol 2002;128:347-352.","DOI":"10.1046\/j.1365-2249.2002.01827.x"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1186\/ar3865"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2014.946404"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.08.019"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.006"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/816424"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2015.1021660"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i4\/1405.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T23:53:32Z","timestamp":1567554812000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i4\/1405.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v22.i4.1405","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}